Key Takeaways
- • Consonance Capital Partners closed Consonance Private Equity III at its $1.35 billion hard cap, roughly four months after the fund went to market.
- • The fund was heavily oversubscribed, drawing commitments from existing limited partners and new investors including endowments, foundations, pension plans and financial institutions globally.
- • The final close was reported on Oct. 9, 2026.
- • Fund III will pursue the same strategy as the firm's earlier funds: lower and middle-market U.S. healthcare companies via growth equity, leveraged buyouts, carve-outs, recapitalizations and special situations.
Summary
New York-based Consonance Capital Partners has closed Consonance Private Equity III at its $1.35 billion hard cap, about four months after the fund was launched to market. The final close was reported on October 9. The fund was heavily oversubscribed, a signal of strong investor demand for the firm's healthcare-focused strategy.
The fundraise drew commitments from existing limited partners as well as a group of new investors. Among the new backers were endowments, foundations, pension plans and financial institutions from around the world, according to the primary report.
Consonance invests in lower and middle-market U.S. healthcare companies. Its toolkit spans growth equity, leveraged buyouts, carve-outs, recapitalizations and special situations. The firm targets businesses that can improve operating efficiency, contain costs and deliver quality care. Fund III will follow the same strategy as the firm's earlier vehicles, and the firm previously invested out of Consonance Private Equity II.
The fundraise drew commitments from existing limited partners as well as a group of new investors. Among the new backers were endowments, foundations, pension plans and financial institutions from around the world, according to the primary report.
Consonance invests in lower and middle-market U.S. healthcare companies. Its toolkit spans growth equity, leveraged buyouts, carve-outs, recapitalizations and special situations. The firm targets businesses that can improve operating efficiency, contain costs and deliver quality care. Fund III will follow the same strategy as the firm's earlier vehicles, and the firm previously invested out of Consonance Private Equity II.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.